Annual EBITDA
$42.97 M
+$92.38 M+186.97%
December 1, 2024
Summary
- As of March 13, 2025, VCYT annual EBITDA is $42.97 million, with the most recent change of +$92.38 million (+186.97%) on December 1, 2024.
- During the last 3 years, VCYT annual EBITDA has risen by +$104.78 million (+169.51%).
- VCYT annual EBITDA is now at all-time high.
Performance
VCYT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$13.18 M
-$9.54 M-42.00%
December 31, 2024
Summary
- As of March 13, 2025, VCYT quarterly EBITDA is $13.18 million, with the most recent change of -$9.54 million (-42.00%) on December 31, 2024.
- Over the past year, VCYT quarterly EBITDA has stayed the same.
- VCYT quarterly EBITDA is now -42.00% below its all-time high of $22.73 million, reached on September 30, 2024.
Performance
VCYT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$52.69 M
+$23.81 M+82.47%
December 31, 2024
Summary
- As of March 13, 2025, VCYT TTM EBITDA is $52.69 million, with the most recent change of +$23.81 million (+82.47%) on December 31, 2024.
- Over the past year, VCYT TTM EBITDA has stayed the same.
- VCYT TTM EBITDA is now at all-time high.
Performance
VCYT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VCYT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +187.0% | 0.0% | 0.0% |
| 3 y3 years | +169.5% | +371.9% | +185.2% |
| 5 y5 years | +650.5% | +316.2% | +775.1% |
VCYT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +169.5% | -42.0% | +158.7% | at high | +185.2% |
| 5 y | 5-year | at high | +169.5% | -42.0% | +130.6% | at high | +183.7% |
| alltime | all time | at high | +169.5% | -42.0% | +130.6% | at high | +183.7% |
Veracyte EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $13.18 M(-42.0%) | $52.69 M(+82.5%) |
| Dec 2024 | $42.97 M(-187.0%) | - | - |
| Sep 2024 | - | $22.73 M(+73.5%) | $28.88 M(-277.2%) |
| Jun 2024 | - | $13.10 M(+255.8%) | -$16.30 M(-47.1%) |
| Mar 2024 | - | $3.68 M(-134.6%) | -$30.81 M(-14.2%) |
| Dec 2023 | -$49.41 M(+379.7%) | -$10.63 M(-52.6%) | -$35.91 M(+62.1%) |
| Sep 2023 | - | -$22.45 M(+1486.4%) | -$22.16 M(+907.5%) |
| Jun 2023 | - | -$1.42 M(+0.1%) | -$2.20 M(-43.2%) |
| Mar 2023 | - | -$1.41 M(-145.3%) | -$3.87 M(-62.4%) |
| Dec 2022 | -$10.30 M(-83.3%) | $3.12 M(-225.3%) | -$10.30 M(-43.6%) |
| Sep 2022 | - | -$2.49 M(-19.3%) | -$18.27 M(-27.1%) |
| Jun 2022 | - | -$3.08 M(-60.7%) | -$25.06 M(-5.8%) |
| Mar 2022 | - | -$7.85 M(+61.8%) | -$26.60 M(-57.0%) |
| Dec 2021 | -$61.81 M(+131.2%) | -$4.85 M(-47.7%) | -$61.81 M(-1.8%) |
| Sep 2021 | - | -$9.28 M(+100.5%) | -$62.93 M(+12.9%) |
| Jun 2021 | - | -$4.63 M(-89.3%) | -$55.73 M(-7.3%) |
| Mar 2021 | - | -$43.06 M(+621.9%) | -$60.11 M(+124.8%) |
| Dec 2020 | -$26.74 M(+242.5%) | -$5.96 M(+186.9%) | -$26.74 M(-0.5%) |
| Sep 2020 | - | -$2.08 M(-76.9%) | -$26.87 M(+9.7%) |
| Jun 2020 | - | -$9.00 M(-7.1%) | -$24.49 M(+45.6%) |
| Mar 2020 | - | -$9.69 M(+58.9%) | -$16.82 M(+115.6%) |
| Dec 2019 | -$7.80 M(-54.4%) | -$6.10 M(-2166.4%) | -$7.80 M(+135.9%) |
| Sep 2019 | - | $295.00 K(-122.1%) | -$3.31 M(-49.8%) |
| Jun 2019 | - | -$1.33 M(+99.6%) | -$6.59 M(-34.3%) |
| Mar 2019 | - | -$669.00 K(-58.2%) | -$10.04 M(-41.4%) |
| Dec 2018 | -$17.12 M | -$1.60 M(-46.5%) | -$17.12 M(-22.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$2.99 M(-37.4%) | -$21.97 M(-9.3%) |
| Jun 2018 | - | -$4.78 M(-38.3%) | -$24.22 M(-3.1%) |
| Mar 2018 | - | -$7.75 M(+20.0%) | -$24.99 M(+5.2%) |
| Dec 2017 | -$23.76 M(-5.5%) | -$6.46 M(+23.2%) | -$23.76 M(+18.8%) |
| Sep 2017 | - | -$5.24 M(-5.5%) | -$19.99 M(+7.0%) |
| Jun 2017 | - | -$5.55 M(-14.9%) | -$18.69 M(-17.5%) |
| Mar 2017 | - | -$6.51 M(+142.4%) | -$22.66 M(-9.9%) |
| Dec 2016 | -$25.14 M(-19.1%) | -$2.69 M(-31.8%) | -$25.14 M(-14.4%) |
| Sep 2016 | - | -$3.94 M(-58.6%) | -$29.36 M(-12.7%) |
| Jun 2016 | - | -$9.52 M(+5.8%) | -$33.63 M(+3.4%) |
| Mar 2016 | - | -$9.00 M(+30.3%) | -$32.51 M(+6.0%) |
| Dec 2015 | -$31.07 M(+11.9%) | -$6.91 M(-15.9%) | -$30.68 M(-2.5%) |
| Sep 2015 | - | -$8.21 M(-2.3%) | -$31.48 M(+2.3%) |
| Jun 2015 | - | -$8.40 M(+17.2%) | -$30.77 M(+7.5%) |
| Mar 2015 | - | -$7.17 M(-6.9%) | -$28.63 M(+3.1%) |
| Dec 2014 | -$27.76 M(+14.0%) | -$7.70 M(+2.7%) | -$27.76 M(+8.6%) |
| Sep 2014 | - | -$7.50 M(+19.6%) | -$25.57 M(+6.7%) |
| Jun 2014 | - | -$6.26 M(-0.5%) | -$23.96 M(+0.0%) |
| Mar 2014 | - | -$6.30 M(+14.4%) | -$23.95 M(-1.6%) |
| Dec 2013 | -$24.35 M(+35.7%) | -$5.51 M(-6.5%) | -$24.35 M(+3.6%) |
| Sep 2013 | - | -$5.89 M(-5.9%) | -$23.50 M(+5.0%) |
| Jun 2013 | - | -$6.25 M(-6.6%) | -$22.37 M(+38.8%) |
| Mar 2013 | - | -$6.70 M(+43.8%) | -$16.12 M(+71.1%) |
| Dec 2012 | -$17.94 M(+29.7%) | -$4.66 M(-2.2%) | -$9.42 M(+97.8%) |
| Sep 2012 | - | -$4.76 M | -$4.76 M |
| Dec 2011 | -$13.83 M | - | - |
FAQ
- What is Veracyte annual EBITDA?
- What is the all time high annual EBITDA for Veracyte?
- What is Veracyte annual EBITDA year-on-year change?
- What is Veracyte quarterly EBITDA?
- What is the all time high quarterly EBITDA for Veracyte?
- What is Veracyte quarterly EBITDA year-on-year change?
- What is Veracyte TTM EBITDA?
- What is the all time high TTM EBITDA for Veracyte?
- What is Veracyte TTM EBITDA year-on-year change?
What is Veracyte annual EBITDA?
The current annual EBITDA of VCYT is $42.97 M
What is the all time high annual EBITDA for Veracyte?
Veracyte all-time high annual EBITDA is $42.97 M
What is Veracyte annual EBITDA year-on-year change?
Over the past year, VCYT annual EBITDA has changed by +$92.38 M (+186.97%)
What is Veracyte quarterly EBITDA?
The current quarterly EBITDA of VCYT is $13.18 M
What is the all time high quarterly EBITDA for Veracyte?
Veracyte all-time high quarterly EBITDA is $22.73 M
What is Veracyte quarterly EBITDA year-on-year change?
Over the past year, VCYT quarterly EBITDA has changed by $0.00 (0.00%)
What is Veracyte TTM EBITDA?
The current TTM EBITDA of VCYT is $52.69 M
What is the all time high TTM EBITDA for Veracyte?
Veracyte all-time high TTM EBITDA is $52.69 M
What is Veracyte TTM EBITDA year-on-year change?
Over the past year, VCYT TTM EBITDA has changed by $0.00 (0.00%)